基因表現市場：依產品類型、應用、技術、工作流程階段、樣本類型、最終使用者和地區分類

基因表現市場預計在2026年達到174.5億美元，預計2033年將達到252.2億美元。預計從2026年到2033年，該市場將以5.4%的複合年成長率成長。

基因表現是一種基本的生物學過程，它將DNA中編碼的遺傳訊息轉化為功能性蛋白質，這些蛋白質驅動細胞活動並決定生物體的特徵。全球基因表現市場涵蓋了廣泛的技術、試劑、儀器和服務，旨在分析、量化和理解各種生物系統中的基因活性模式。這個快速發展的市場包括先進的分析平台，例如RNA定序、微陣列、定量PCR和新一代定序技術，使研究人員能夠解析複雜的基因調控機制。

該市場涵蓋廣泛的應用領域，從基礎研究、藥物發現與開發到個人化醫療、農業生物技術和臨床診斷。隨著基因組研究投入的不斷增加、遺傳疾病盛行率的上升以及精準醫療方法日益受到重視，基因表現市場在加深科學理解和推進治療性介入發揮著至關重要的作用。人工智慧 (AI) 和機器學習演算法與基因表現分析平台的融合，進一步提升了數據解讀能力，使研究人員能夠從龐大的基因組資料集中提取有意義的信息，並加速生命科學領域的突破性發現。

市場動態

全球基因表現市場受多種關鍵因素驅動，這些因素正在從根本上改變分子生物學研究和臨床應用的模式。全球政府和私人機構對基因組研究資金的快速成長是主要催化劑，使研究人員能夠投資先進的基因表現分析技術並擴展其研究能力。隨著癌症、遺傳性疾病和複雜疾病的日益普遍，全面的基因表現分析對於理解疾病機制和開發標靶治療方法至關重要，從而推動了對先進分析平台的顯著需求。

個人化醫療方法的日益普及，即根據個別基因譜客製化治療方案，顯著提高了臨床對精準基因表現分析的需求。此外，新一代定序、RNA定序技術和高性能篩檢平台的進步，提高了分析精度並降低了營運成本，使研究機構和醫療機構更容易獲得基因表現分析服務。然而，市場也存在著許多限制因素。首先，先進的基因表現分析儀需要大量的資金投入，這可能會限制小規模研究機構和新興市場機構的使用。其次，數據解讀的複雜性以及對專業生物資訊學知識的需求，也為缺乏足夠技術資源和熟練人員的機構帶來了障礙。

此外，監管合規要求和漫長的臨床應用核准流程可能會延緩參與企業進入市場，並增加研發成本。儘管面臨這些挑戰，基因表現分析在農業生物技術、環境監測和工業生物技術領域的廣泛應用也帶來了巨大的機會。人工智慧 (AI) 和機器學習演算法的日益融合，為開發更先進的分析平台創造了機會，這些平台能夠處理複雜的基因組資料集，並為研究人員和臨床醫生提供可操作的見解。

本研究的關鍵特徵

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數創建了全球基因表現市場主要公司的概況：公司亮點、產品系列、主要特徵、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 全球基因表現市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過分析全球基因表現市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球基因表現市場：依產品類型分類，2021-2033年

• 設備（PCR系統、次世代定序系統、微陣列掃描器等）
• 耗材及試劑（試劑盒、檢測方法及探針、DNA晶片等）
• 軟體和服務

第5章 全球基因表現市場：依應用領域分類，2021-2033年

• 藥物發現和藥物開發
• 臨床診斷
• 研究與開發

第6章 全球基因表現市場：依技術分類，2021-2033年

• DNA微陣列
• 基於PCR的（qPCR、RT-PCR）
• RNA定序（RNA-Seq）
• Northern印跡法
• 下一代定序（NGS）
• 基因表現系列分析（SAGE）

第7章 全球基因表現市場：依工作流程階段分類，2021-2033年

• 樣本採集和預處理
• RNA分離與純化
• cDNA合成與擴增
• 檢測與定量
• 數據分析與解讀

第8章 全球基因表現市場：依樣本類型分類，2021-2033年

• 人類樣本
• 動物樣本
• 微生物樣本

第9章 全球基因表現市場：依最終用戶分類，2021-2033年

• 學術研究機構
• 製藥和生物技術公司
• 受託研究機構（CRO）
• 醫院和臨床檢查室

第10章 全球基因表現市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第11章 競爭格局

• Thermo Fisher Scientific Inc
• Agilent Technologies Inc
• Illumina Inc
• QIAGEN NV
• Bio-Rad Laboratories Inc
• Roche Diagnostics
• PerkinElmer Inc
• Takara Bio Inc
• Promega Corporation
• GE Healthcare
• Pacific Biosciences of California Inc
• Oxford Nanopore Technologies
• Fluidigm Corporation
• Lonza Group Ltd
• Eurofins Genomics

第12章 分析師建議

• 機會分析
• 分析師意見
• 一致的機會地圖

第13章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Gene Expression Market is estimated to be valued at USD 17.45 Bn in 2026 and is expected to reach USD 25.22 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.

Gene expression represents a fundamental biological process through which genetic information encoded in DNA is converted into functional proteins that drive cellular activities and determine organism characteristics. The global gene expression market encompasses a comprehensive range of technologies, reagents, instruments, and services designed to analyze, quantify, and understand gene activity patterns across various biological systems. This rapidly evolving market includes sophisticated analytical platforms such as RNA sequencing, microarrays, quantitative PCR, and next-generation sequencing technologies that enable researchers to decode complex gene regulatory mechanisms.

The market serves diverse applications spanning basic research, drug discovery and development, personalized medicine, agricultural biotechnology, and clinical diagnostics. With increasing investments in genomics research, rising prevalence of genetic disorders, and growing emphasis on precision medicine approaches, the gene expression market has become pivotal in advancing scientific understanding and therapeutic interventions. The integration of artificial intelligence and machine learning algorithms with gene expression analysis platforms is further revolutionizing data interpretation capabilities, enabling researchers to extract meaningful insights from vast genomic datasets and accelerate breakthrough discoveries in life sciences.

Market Dynamics

The global gene expression market is propelled by several key drivers that are fundamentally reshaping the landscape of molecular biology research and clinical applications. The exponential growth in genomics research funding from government agencies and private organizations worldwide serves as a primary catalyst, enabling researchers to invest in advanced gene expression analysis technologies and expand their investigative capabilities. The increasing prevalence of cancer, genetic disorders, and complex diseases necessitates comprehensive gene expression profiling to understand disease mechanisms and develop targeted therapeutic interventions, driving substantial demand for sophisticated analytical platforms.

The rising adoption of personalized medicine approaches, where treatment strategies are tailored based on individual genetic profiles, significantly amplifies the need for accurate gene expression analysis in clinical settings. Additionally, technological advancements in next-generation sequencing, RNA-seq methodologies, and high-throughput screening platforms are enhancing analytical precision and reducing operational costs, making gene expression analysis more accessible to research institutions and healthcare facilities. However, the market faces notable restraints including the high capital investment requirements for advanced gene expression analysis equipment, which can limit adoption among smaller research organizations and emerging market institutions. The complexity of data interpretation and the need for specialized bioinformatics expertise create barriers for organizations lacking adequate technical resources and skilled personnel.

Regulatory compliance requirements and lengthy approval processes for clinical applications can delay market penetration and increase development costs for market participants. Despite these challenges, significant opportunities emerge from the expanding applications of gene expression analysis in agricultural biotechnology, environmental monitoring, and industrial biotechnology sectors. The growing integration of artificial intelligence and machine learning algorithms presents opportunities to develop more sophisticated analytical platforms capable of processing complex genomic datasets and providing actionable insights for researchers and clinicians.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global gene expression market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, QIAGEN N.V, Bio-Rad Laboratories Inc, Roche Diagnostics, PerkinElmer Inc, Takara Bio Inc, Promega Corporation, GE Healthcare, Pacific Biosciences of California Inc, Oxford Nanopore Technologies, Fluidigm Corporation, Lonza Group Ltd, and Eurofins Genomics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global gene expression market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene expression market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
• Instruments (PCR Systems, Next-Generation Sequencing Systems, Microarray Scanners, etc.)
• Consumables and Reagents (Kits, Assays and Probes, DNA Chips etc.)
• Software and Services
• Application Insights (Revenue, USD Bn, 2021 - 2033)
• Drug Discovery and Development
• Clinical Diagnostics
• Research and Development
• Technology Insights (Revenue, USD Bn, 2021 - 2033)
• DNA Microarray
• PCR-Based (qPCR, RT-PCR)
• RNA Sequencing (RNA-Seq)
• Northern Blotting
• Next-Generation Sequencing (NGS)
• Serial Analysis of Gene Expression (SAGE)
• Workflow Stage Insights (Revenue, USD Bn, 2021 - 2033)
• Sample Collection and Preparation
• RNA Isolation and Purification
• cDNA Synthesis and Amplification
• Detection and Quantification
• Data Analysis and Interpretation
• Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
• Human Samples
• Animal Samples
• Microbial Samples
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Hospitals and Clinical Laboratories
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Thermo Fisher Scientific Inc
• Agilent Technologies Inc
• Illumina Inc
• QIAGEN N.V
• Bio-Rad Laboratories Inc
• Roche Diagnostics
• PerkinElmer Inc
• Takara Bio Inc
• Promega Corporation
• GE Healthcare
• Pacific Biosciences of California Inc
• Oxford Nanopore Technologies
• Fluidigm Corporation
• Lonza Group Ltd
• Eurofins Genomics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Gene Expression Market, By Product Type
  • Global Gene Expression Market, By Application
  • Global Gene Expression Market, By Technology
  • Global Gene Expression Market, By Workflow Stage
  • Global Gene Expression Market, By Sample Type
  • Global Gene Expression Market, By End User
  • Global Gene Expression Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Gene Expression Market, By Product Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Instruments (PCR Systems, Next-Generation Sequencing Systems, Microarray Scanners, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Consumables and Reagents (Kits, Assays and Probes, DNA Chips, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Software and Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Gene Expression Market, By Application, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Clinical Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Research and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Gene Expression Market, By Technology, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• DNA Microarray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• PCR-Based (qPCR, RT-PCR)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• RNA Sequencing (RNA-Seq)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Northern Blotting
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Next-Generation Sequencing (NGS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Serial Analysis of Gene Expression (SAGE)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Gene Expression Market, By Workflow Stage, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Sample Collection and Preparation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• RNA Isolation and Purification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• cDNA Synthesis and Amplification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Detection and Quantification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Data Analysis and Interpretation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Gene Expression Market, By Sample Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Human Samples
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Animal Samples
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Microbial Samples
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Gene Expression Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Hospitals and Clinical Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Gene Expression Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive landscape

• Thermo Fisher Scientific Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN N.V
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PerkinElmer Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takara Bio Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Promega Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pacific Biosciences of California Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Oxford Nanopore Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fluidigm Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lonza Group Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eurofins Genomics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us